Antiretroviral Therapy: Pharmacokinetic Considerations in Patients with Renal or Hepatic Impairment

Author： McCabe Sarah M.   Qing   Slish Judianne C.   Catanzaro Linda M.   Sheth Neha   DiCenzo Robert   Morse Gene D.  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.47, Iss.3, 2008-01, pp. : 153-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic Considerations of Perinatal Antiretroviral Therapy

By  

Current Drug Metabolism, Vol. 13, Iss. 6, 2012-07 ,pp. : 744-759

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic Considerations for Antimicrobial Therapy in Patients Receiving Renal Replacement Therapy

By Pea Federico  

Clinical Pharmacokinetics, Vol. 46, Iss. 12, 2007-01 ,pp. : 997-1038

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Considerations in the Treatment of Tuberculosis in Patients with Renal Failure

By Launay-Vacher Vincent   Izzedine Hassane   Deray Gilbert  

Clinical Pharmacokinetics, Vol. 44, Iss. 3, 2005-01 ,pp. : 221-235

Adis International

Access to resources Recommend Favorite

Immunosuppressive Therapy for Paediatric Transplant Patients: Pharmacokinetic Considerations

By Fernández de Gatta M.d.M.  

Clinical Pharmacokinetics, Vol. 41, Iss. 2, 2002-01 ,pp. : 115-135

Adis International

Access to resources Recommend Favorite

The dosing of anidulafungin does not require adjustment in patients with hepatic or renal impairment

By  

Inpharma, Vol. 1, Iss. 1585, 2007-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite